CN100488471C - Nano-scale antibacterial and antiviral condom - Google Patents
Nano-scale antibacterial and antiviral condom Download PDFInfo
- Publication number
- CN100488471C CN100488471C CNB2006100366600A CN200610036660A CN100488471C CN 100488471 C CN100488471 C CN 100488471C CN B2006100366600 A CNB2006100366600 A CN B2006100366600A CN 200610036660 A CN200610036660 A CN 200610036660A CN 100488471 C CN100488471 C CN 100488471C
- Authority
- CN
- China
- Prior art keywords
- condom
- interferon
- antiviral
- antibacterial
- polyurethane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 30
- 230000000840 anti-viral effect Effects 0.000 title claims abstract description 17
- 102000014150 Interferons Human genes 0.000 claims abstract description 36
- 108010050904 Interferons Proteins 0.000 claims abstract description 36
- 229940079322 interferon Drugs 0.000 claims abstract description 35
- 239000004814 polyurethane Substances 0.000 claims description 31
- 229920002635 polyurethane Polymers 0.000 claims description 26
- 239000000463 material Substances 0.000 claims description 21
- 230000003115 biocidal effect Effects 0.000 claims description 12
- 239000003443 antiviral agent Substances 0.000 claims description 7
- 150000001408 amides Chemical class 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 108090000467 Interferon-beta Proteins 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 102000003996 Interferon-beta Human genes 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 11
- 208000006374 Uterine Cervicitis Diseases 0.000 abstract description 10
- 206010008323 cervicitis Diseases 0.000 abstract description 10
- 241000700605 Viruses Species 0.000 abstract description 9
- 206010061218 Inflammation Diseases 0.000 abstract description 4
- 230000004054 inflammatory process Effects 0.000 abstract description 4
- 230000001580 bacterial effect Effects 0.000 abstract description 3
- 239000003433 contraceptive agent Substances 0.000 abstract description 3
- 230000002254 contraceptive effect Effects 0.000 abstract description 3
- 230000006378 damage Effects 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 3
- 241000606161 Chlamydia Species 0.000 abstract description 2
- 208000010362 Protozoan Infections Diseases 0.000 abstract description 2
- 208000027418 Wounds and injury Diseases 0.000 abstract description 2
- 230000009471 action Effects 0.000 abstract description 2
- 208000014674 injury Diseases 0.000 abstract description 2
- 238000011160 research Methods 0.000 abstract description 2
- 230000001954 sterilising effect Effects 0.000 abstract description 2
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 208000007190 Chlamydia Infections Diseases 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 229940047124 interferons Drugs 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 10
- 206010018612 Gonorrhoea Diseases 0.000 description 9
- 208000001786 gonorrhea Diseases 0.000 description 9
- 102000006992 Interferon-alpha Human genes 0.000 description 8
- 108010047761 Interferon-alpha Proteins 0.000 description 8
- 125000004429 atom Chemical group 0.000 description 7
- OHDXDNUPVVYWOV-UHFFFAOYSA-N n-methyl-1-(2-naphthalen-1-ylsulfanylphenyl)methanamine Chemical compound CNCC1=CC=CC=C1SC1=CC=CC2=CC=CC=C12 OHDXDNUPVVYWOV-UHFFFAOYSA-N 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 229940079593 drug Drugs 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 6
- 238000012258 culturing Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 108010054267 Interferon Receptors Proteins 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 230000002949 hemolytic effect Effects 0.000 description 3
- 239000002105 nanoparticle Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- -1 2 '-5 ' A synzyme Proteins 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- 102000011195 Profilin Human genes 0.000 description 2
- 108050001408 Profilin Proteins 0.000 description 2
- 102000001253 Protein Kinase Human genes 0.000 description 2
- 208000019802 Sexually transmitted disease Diseases 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 230000010065 bacterial adhesion Effects 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000006303 photolysis reaction Methods 0.000 description 2
- 230000015843 photosynthesis, light reaction Effects 0.000 description 2
- 108060006633 protein kinase Proteins 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 150000003335 secondary amines Chemical class 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 101001098814 Dictyostelium discoideum 3',5'-cyclic-nucleotide phosphodiesterase regA Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 102000001617 Interferon Receptors Human genes 0.000 description 1
- 102100026720 Interferon beta Human genes 0.000 description 1
- 102100037850 Interferon gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 102000005877 Peptide Initiation Factors Human genes 0.000 description 1
- 108010044843 Peptide Initiation Factors Proteins 0.000 description 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
- 206010039251 Rubber sensitivity Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- SIIZPVYVXNXXQG-KGXOGWRBSA-N [(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-4-[[(3s,4r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-3-hydroxyoxolan-2-yl]methyl [(2r,4r,5r)-2-(6-aminopurin-9-yl)-4-hydroxy-5-(phosphonooxymethyl)oxolan-3-yl] hydrogen phosphate Polymers C1=NC2=C(N)N=CN=C2N1[C@@H]1O[C@H](COP(O)(=O)OC2[C@@H](O[C@H](COP(O)(O)=O)[C@H]2O)N2C3=NC=NC(N)=C3N=C2)[C@@H](O)[C@H]1OP(O)(=O)OCC([C@@H](O)[C@H]1O)OC1N1C(N=CN=C2N)=C2N=C1 SIIZPVYVXNXXQG-KGXOGWRBSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940124289 antineoplastic interferon Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000012661 block copolymerization Methods 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- KMQAPZBMEMMKSS-UHFFFAOYSA-K calcium;magnesium;phosphate Chemical compound [Mg+2].[Ca+2].[O-]P([O-])([O-])=O KMQAPZBMEMMKSS-UHFFFAOYSA-K 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000005253 cladding Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 108010087236 cobra venom endonuclease Proteins 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- UXGNZZKBCMGWAZ-UHFFFAOYSA-N dimethylformamide dmf Chemical compound CN(C)C=O.CN(C)C=O UXGNZZKBCMGWAZ-UHFFFAOYSA-N 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 150000002270 gangliosides Chemical class 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 210000003917 human chromosome Anatomy 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920006264 polyurethane film Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Landscapes
- Materials For Medical Uses (AREA)
Abstract
The invention relates to a condom and discloses a nano-scale antibacterial and antiviral condom. The invention grafts the interferon on the condom, which has better sterilization effect than smearing the interferon on the condom. After the interferon is grafted and fixed on the condom, the bactericidal activity is improved to 6.3 percent from 2.1 percent of free interferon within one hour, and 3 times of bactericidal activity is shown. Therefore, the condom which is an important contraceptive tool has more functions and even assists in treating gynecological inflammation, wherein the gynecological inflammation comprises cervicitis with complex etiology, which is considered to be related to physical and chemical stimulation, injury or bacterial, chlamydia and protozoan infection in the past, and about 30-40% of patients have positive HSV and HPV detection in recent years through a large amount of clinical research data. Interferons inhibit bacterial growth and also inhibit replication of viruses in host cells and have a wide range of actions.
Description
Technical field
The present invention relates to a kind of condom, specifically, relate to a kind of nano antibiotic antiviral condom.
Background technology
Condom is to use the most general contraceptive device in the world, the annual number that consumes is hundreds of millions of, and condom is to not injury of human body, other contraceptive devices that compare have much more very advantages, since eighties of last century since the nineties, a kind of novel polyurethane condom is developed, the advantage that not only has rubber condoms, close such as slippage rate and breakage rate, and be applicable to crowd to the rubber sensitivity, moreover, it is thinner that polyurethane condom can be made, and gives better sensation.
Cervicitis is a kind of gynecological common disease, mainly be divided into gonorrhea type cervicitis and non-gonorrhea cervicitis, gonorrhea type cervicitis is mainly by gonorrhea diplococcus, staphylococcus aureus and Hemolytic streptococcus cause, but not the gonorrhea cervicitis mainly causes the interferon therapy cervicitis mainly by kill virus by virus, and its mechanism is quite ripe.The common minimizing sexual life in various degree of cervicitis patient, and because general condom effect only limits to contraception and shielding virus, and and the antibiotic targetedly and antiviral of impotentia, so if a kind of successful development of strong antibacterial and antiviral condom is arranged, not only can untie cervicitis patient's hearty cord, also more effectively cooperative drug is prevented and treated sexually transmitted disease (STD), the infection of acquired immune deficiency syndrome (AIDS).
IFN is under inducer and some effect of cytokines, and the histone matter by the cytogene coding produces has high activity and multiple function.The virus-free specificity of IFN, a kind of IFN of virus induction is also effective to its virus, but species specificity is arranged, and the IFN that mice produces is invalid in human body.The interference of known person have 3 kinds: IFN-α is a LeIF, and IFN-β is the fibroblast interferon, and plain (a kind of cytokine that the T lymphocyte produces) done in the i.e. immunity of IFN-γ; The first two kind I type, back one kind II type.The gene of coding I type IFN is positioned on human the 9th pair of chromosome, and the gene of coding II type IFN is positioned on the 12nd pair of chromosome.Interferon at first acts on the interferon receptor 2 system on the cell membrane of contiguous uninfection, and the binding site that this system is made up of ganglioside and one may be made up of the activation site that glycoprotein is formed.Existing known I type interferon receptors gene is on human chromosome G21 is long-armed, and II type interferon receptors gene is positioned on the 6th pair of chromosome, and this belongs to specificity with regard to having determined IFN to have certain journey.After IFN and receptors bind, produce a kind of special factor, antiviral protein (AVP) gene is removed suppressed, transcribe and translate AVP, mainly be protein kinase, 2 '-5 ' A synzyme, phosphodiesterase, these enzymes have substantial connection with the performance antiviral activity.Wherein two kinds of enzymes must activate through bifilar RNA and ATP, and one be protein kinase, and the initiation factors 2 (eIF-2) that can make synthetic protein after the activation is inactivation with phosphorylation, and Profilin matter is synthesized; Another kind is 2 '-5 a ' A synzyme, and activation back catalysis Synthetic 2 '-5 ' oligoadenylate activates potential Cobra venom endonuclease again, makes the virus mRNA degraded, and it is synthetic to suppress virus protein.In addition, the phosphodiesterase 2 '-5 ' A that can degrade can remove the CCA end of tRNA again, and Profilin is synthetic.
Interferon is a kind of medicine of broad-spectrum antibacterial antiviral, if there is a kind of condom can not only possess the advantage of common condom, but also the effect of treatment can anti-bacteria and anti-virus be arranged, and such condom will be a breakthrough of contraception armarium.
Summary of the invention
The objective of the invention is to overcome the deficiency that condom exists, provide a kind of can be antibiotic again can antiviral condom, be applied to prevention and treat various gynaecopathias.
Another object of the present invention provides the preparation method of above-mentioned condom.
To achieve these goals, antibiotic antiviral condom of the present invention is fixed on the antibacterial and antiviral drug grafting on the condom.The condom material can be various macromolecular materials, and preferred condom material is a polyurethane.
Above-mentioned antibacterial and antiviral drug can be various antibiotic and medicines antiviral effect of playing.For example has the antibiotic antineoplastic interferon of broad spectrum antiphlogistic disease.
The present invention adopts the photofixation method that the bacteriostatic grafting is fixed on the macromolecular material of condom.Earlier interferon is added in the solution that contains the inferior amide of N-succinum the ice bath stirring reaction; Spread upon the condom outer surface then, under ultraviolet or 300~800nm visible light, shine.Utilize the photochemical fixation method will have the component of special properties or the method that biomolecule is coupled to material surface, it can block copolymerization, grafting improves the surface character of material own but does not change material body character, reduce unordered crosslinked that the purpose coating reagent produces on the medical macromolecular materials surface, and improve the biocompatibility and the blood compatibility of polyurethane material.
Its grafting principle is suc as formula shown in (I), (II):
Photolytic activity IFN[is connected to IFN on the hot active group of the inferior amide of N-(4-azidobenzoic acid base) succinum by azido fracture] in fragrant azido group through the UV radiation excitation, irreversible photolysis takes place, azido is decomposed into nitrogen and the high nitrence intermedium of active-energy, this intermedium is opened hydrocarbon key in the macromolecule, nitrogen and carbon generation necleophilic reaction, and hydrogen that seizes and carbon atom formation secondary amine, the result makes molecules of interest (IFN) receive on the polyurethane surface with covalent bond.
Compared with prior art, the present invention has following beneficial effect: the present invention is grafted on interferon on the condom, and this has better bactericidal effect than interferon is spread upon on condom.After the interferon grafting was fixed on condom, the bactericidal activity in hour brought up to 6.3% by 2.1% of free interferon, demonstrates 3 times bactericidal activity.Thereby give condom this important birth control instrument more function, even assistance treatment gynecological inflammation, and gynecological inflammation comprises the cause of disease complexity of cervicitis, think relevant in the past with physicochemical irritation, damage or antibacterial, chlamydia, protozoan infection, a large amount of in recent years clinical research datas find have 30%~40% interior HSV of patient's body and HPV to detect positive approximately.Interferon can suppress the growth of antibacterial, also can suppress virus in host cell, duplicate and sphere of action extensive.
Description of drawings
Fig. 1 is polyurethane grafted figure under the field emission scanning electron microscope;
Fig. 2 is that laser scanning worker focusing microscope is for the light compositing interferon slice map on the polyurethane film;
Fig. 3 is fixed on bactericidal effect figure on the condom polyurethane for interferon-' alpha ';
Fig. 4 is the free bactericidal effect figure of interferon-' alpha ';
Wherein, among Fig. 1, A is no grafted polyurethane Electronic Speculum figure; B, C, D are the interferon grafted polyurethane Electronic Speculum figure of different proportion chi.Among Fig. 2, first passage is the FITC fluorescence channel, and second channel is a polyurethane surface transmission phase, and third channel is the stacks of two passages.
The specific embodiment
The grafting of embodiment 1 interferon
1. with IFN-α (30 μ g, contain inferior amide (the 61.5 μ g of N-succinum 0.002 μ mol) add 3ml, 0.2 in dimethylformamide DMF/PBS μ mol) (volume ratio is 4: the 1) solution, ice bath stirring reaction 48h (4 ℃), behind the end of synthesis, use the deutero-IFN-α of ultrafiltration membrane (milipore molecutII, 10k Na) purification azidophenyl respectively.
2. before the photo-immobilization polyurethane condom is cut into diameter and is positioned over 24 hole tissue culturing plates for the 10mm round sheet, do following the processing afterwards: respectively with photolytic activity IFN-α with six kinds of concentration (0.01 μ g, 0.025 μ g, 0.05 μ g, 0.075 μ g, 0.1 μ g, 0.25 μ g) add in the 24 hole tissue culturing plates, after having added medicine, Jiang Geban places refrigerator, lyophilization (4 ℃), (15W) shines 20min in the 2cm place down under uviol lamp then, utilize the very active characteristics of azido, active IFN be fixed on the PU material, behind the photo-immobilization with (pH7.4) solution cyclic washing PU30 time of no calcium magnesium phosphate buffer solution PBS (-).
The form of embodiment 2 electron microscopic observation photo-immobilization IFN-α
The A of Fig. 1, B, C, D is respectively the polyurethane surface behind the active IFN-α of observed polyurethane and grafting under the field emission scanning electron microscope, can see there is not the smooth empty of the synthetic polyurethane surface of photofixation, and form one deck orderly protein layer that is evenly distributed at polyurethane surface through the interferon of can seeing after fixing, also just like Fig. 4 D a spot of agglomeration appears then, because interferon molecule is little.From Fig. 1 D is example, observes with 20000 times, uses Imagepro plus5.0 that picture under the Electronic Speculum is analyzed, and parameter is as follows:
Table 1 is Fig. 1 D reunion data analysis
Typical object area in: | pixels |
Original count | 390 |
Single objects | 351 |
Clusters | 39 |
Objects in clusters | 83 |
Total objects | 434 |
Typical object area | 13.05897 |
Table 2 is that the interferon particle shape of Fig. 1 D is learned data analysis
Stats | Area | Diameter (mean) |
Min | 5 | 2.874342 |
(Obj.#) | 370 | 638 |
Max | 43 | 10.98799 |
(Obj.#) | 2588 | 10406 |
Range | 38 | 8.113649 |
Mean | 13.058974 | 4.323231 |
Std.Dev | 8.6403408 | 1.28626 |
Sum | 5093 | 1686.06 |
Samples | 390 | 390 |
Computer has carried out scanning analysis to 10406 objects among Fig. 1 D, the granule that meets IFN has 390, the granule mean diameter is between 28.7nm and 109.9nm, mean diameter is 43.2nm, individual molecule granule number in visual field is approximately 351, particle agglomeration has 39 places, and the polyurethane surface of Figure 1A is very smooth, and the increase of surface atom number has caused the rapid variation of character.This surface atom number reduces with nano-particles size and the qualitative skin effect that causes after sharply increasing.We think that the polyurethane behind the photo-immobilization can think the nanometer level bioactive material, interferon particles is dispersed to the nanoscale structures size reduces, and the surface atom number is increased sharply, and specific surface area, surface area and Surface binding energy increase rapidly.From chemical terms, the increase of surface atom number, the deficiency of Atomic coordinate also have the residing bonding state of surface atom or bonding environment and original interferon molecule and polyurethane atom that very big difference is arranged, usually be in undersaturated condition, cause nano material to have high surface activity, be easy to combine with other atom.Possess free more not available other characteristics of pure interferon, progressively discharge interferon such as photolysis secondary amine key under certain condition.It is all relevant therewith that high catalytic activity that nano-particle shows and high response, nanoparticle are easy to reunite etc.Embodiment 3 laser scanning co-focusing microscopes (CSLM) are observed the form of IFN-α
Two passages carry out the burnt observation of scan laser microphotograph copolymerization, and first passage is observed the IFN-α of dyeing FITC, and second passage projection shows the polyurethane material surface, and the 3rd passage superposes.The material surface interferon is carried out six sections, obtain Fig. 2.
FITC cancellation extremely easily, but can the be special IFN-alpha protein be dyeed can see that the IFN molecule is not simply to be attached to material surface, but firm polyurethane surface and the biologically active of being grafted on.
Embodiment 4 bacteriostatic experiments
All experimental articles are made sterilization treatment in High Temperature High Pressure, respectively with three kinds of pathogenic bacterium (gonorrhea diplococcus, staphylococcus aureuses, Hemolytic streptococcus) in the culture medium flat plate purification, the individual plant bacterium colony appears, and choose the individual plant bacterium colony and insert physiological saline solution, microscopically is observed, and dilution is for about 10
5Bacteria suspension about CFU/ml (colony formine unit, colony-forming units), each is drawn 1ml and splashes into culture medium, and L type spreader is evenly coated each media surface.
Grafting concentration is divided into six, and the grafting face of photo-immobilization polyurethane is a single face, so use aseptic nipper to place the culture medium top layer material difference obverse and reverse of six concentration, uses L type spreader with bacterium liquid cladding material surface.
Blank controll is an aseptic culture medium, control2 is pure antibacterial culturing, and control3 is no grafting PU antibacterial culturing, and control4 is a latex thin film antibacterial culturing, control5 cultivates for free photolytic activity interferon maximum concentration, and control6 cultivates for the polyurethane powder maximum concentration.
Condition of culture: 37 ℃, 5% CO
2Incubator is cultivated gonorrhea diplococcus, and the common micro-organisms incubator is cultivated staphylococcus aureus and Hemolytic streptococcus for 37 ℃.
Behind 24h and the 72h, except control, other are cultivated and all find no obvious inhibition zone, concrete condition such as following table 3,4.
Table 3 is for cultivating the antibacterial situation of 24h
Table 4 is for cultivating the antibacterial situation of 72h
From table 3, the result of table 4 as can be seen, bigger among six contrasts owing to concentration, the efficacy of a drug of free light compositing interferon and pure interferon can be killed all antibacterials rapidly, very fast of diffusion velocity, and latex material is very fast by bacterial adhesion, there is not the PU of fixed drug in 24h, to have in the bacteriostasis property 72h gradually by bacterial adhesion, and tangible haemolysis circle appears in material below culture medium, even and the positive Cmin of placing of the PU of fixed medicine also can long term inhibition media surface bacterial growth, bacteriostasis rate reaches 100%, the haemolysis circle does not appear in the culture medium that the PU reverse side of fixed drug is placed under medicine, the bacteriostasis property of this proof interferon photo-immobilization polyurethane material is fine.
Embodiment 5 bactericidal effects relatively
Experimental technique: gonorrhea diplococcus is cultivated concentration about 10 as calculated
7CFU/ml, pour test tube A and B into, the A fixedly polyurethane material of the interferon of least concentration immerses test tube, B will identical grafting amount with the fixed drug polyurethane surface the least concentration interferon put into test tube, after 37 ℃ of shaking tables are cultivated one hour, detect A and B respectively with flow cytometer, the results are shown in Figure 3 and Fig. 4.
Experimental result: shown in Figure 4 as Fig. 3, the effect of antibacterial (gonorrhea diplococcus) effect specific ionization of fixing back interferon will be got well.After the interferon grafting was fixed on condom, the bactericidal activity in hour brought up to 6.3% by 2.1% of free interferon.
Claims (6)
1, a kind of antibiotic antiviral condom comprises antibacterial and antiviral drug and condom, it is characterized in that described antibacterial and antiviral drug is that grafting is fixed on the condom.
2, antibiotic antiviral condom according to claim 1, the material that it is characterized in that described condom is a polyurethane.
3, antibiotic antiviral condom according to claim 1 and 2 is characterized in that described antibacterial and antiviral drug is an interferon.
4, antibiotic antiviral condom according to claim 3 is characterized in that described interferon is LeIF or fiblaferon.
5, the preparation method of the described antibiotic antiviral condom of claim 1 is characterized in that adopting the photofixation method that the antibacterial and antiviral drug grafting is fixed in the contraception.
6, preparation method according to claim 5 is characterized in that comprising the steps: antibacterial and antiviral drug being added in the solution that contains the inferior amide of N-succinum the ice bath stirring reaction; Spread upon the condom outer surface then, under ultraviolet or 300~800nm visible light, shine.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100366600A CN100488471C (en) | 2006-07-25 | 2006-07-25 | Nano-scale antibacterial and antiviral condom |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100366600A CN100488471C (en) | 2006-07-25 | 2006-07-25 | Nano-scale antibacterial and antiviral condom |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1919160A CN1919160A (en) | 2007-02-28 |
CN100488471C true CN100488471C (en) | 2009-05-20 |
Family
ID=37777101
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100366600A Expired - Fee Related CN100488471C (en) | 2006-07-25 | 2006-07-25 | Nano-scale antibacterial and antiviral condom |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100488471C (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101569576B (en) * | 2008-05-04 | 2011-06-15 | 吴智尧 | Long-acting type condom with sterilization function and producing method thereof |
CN102675464A (en) * | 2010-06-11 | 2012-09-19 | 华南师范大学 | Co-immobilized cytokine, preparation method and applications thereof |
CN102532579A (en) * | 2012-01-11 | 2012-07-04 | 华南师范大学 | Antibacterial latex contraceptive material provided with grafted nanoscale IFN (Interferon)-alpha |
CN103892956B (en) * | 2012-12-27 | 2018-10-19 | 浙江相伴乳胶制品有限公司 | A kind of sheath with antivirus action |
CN103463671B (en) * | 2013-09-11 | 2015-04-22 | 华南师范大学 | Antibacterial and antiviral sanitary pad |
CN107157640A (en) * | 2017-05-14 | 2017-09-15 | 郭宝煊 | Intelligent sheath |
CN108379559A (en) * | 2018-05-23 | 2018-08-10 | 华中农业大学 | Application of the grass carp interferon 1 in preparing antibacterials |
CN113208799A (en) * | 2021-06-07 | 2021-08-06 | 经鸿纬健康科技发展(上海)有限公司 | A polyurethane condom containing flavonoid antibacterial active factor |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2161043C1 (en) * | 2000-04-13 | 2000-12-27 | Гапонюк Петр Яковлевич | Agent of intimate designation for males |
CN1408327A (en) * | 2001-09-03 | 2003-04-09 | 汪志新 | Nano condom |
CN1154454C (en) * | 2000-12-20 | 2004-06-23 | 天津市亚马逊科技发展有限公司 | Nano composite condom and making method thereof |
CN1686065A (en) * | 2005-06-09 | 2005-10-26 | 易乃君 | Safety enhanced condom |
-
2006
- 2006-07-25 CN CNB2006100366600A patent/CN100488471C/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2161043C1 (en) * | 2000-04-13 | 2000-12-27 | Гапонюк Петр Яковлевич | Agent of intimate designation for males |
CN1154454C (en) * | 2000-12-20 | 2004-06-23 | 天津市亚马逊科技发展有限公司 | Nano composite condom and making method thereof |
CN1408327A (en) * | 2001-09-03 | 2003-04-09 | 汪志新 | Nano condom |
CN1686065A (en) * | 2005-06-09 | 2005-10-26 | 易乃君 | Safety enhanced condom |
Also Published As
Publication number | Publication date |
---|---|
CN1919160A (en) | 2007-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100488471C (en) | Nano-scale antibacterial and antiviral condom | |
Dwivedi et al. | In vivo diabetic wound healing with nanofibrous scaffolds modified with gentamicin and recombinant human epidermal growth factor | |
Akbarzadeh et al. | An overview application of silver nanoparticles in inhibition of herpes simplex virus | |
Popat et al. | Decreased Staphylococcus epidermis adhesion and increased osteoblast functionality on antibiotic-loaded titania nanotubes | |
CN105597159B (en) | Antibacterial product based on gold nanoparticles and preparation method and application thereof | |
CN103566371A (en) | Antimicrobial physical method | |
Klippstein et al. | Silver nanoparticles interactions with the immune system: implications for health and disease | |
Li et al. | Preparation of gentamicin-loaded electrospun coating on titanium implants and a study of their properties in vitro | |
WO2019169873A1 (en) | Nano antibacterial gel for treating wound infection and promoting healing and preparation method therefor | |
Abbaszadeh et al. | Effects of chitosan/nano selenium biofilm on infected wound healing in rats; an experimental study | |
Zhang et al. | Infection-responsive long-term antibacterial bone plates for open fracture therapy | |
Zazo et al. | Applications of metallic nanoparticles in antimicrobial therapy | |
Huang et al. | MXene‐Decorated Nanofibrous Membrane with Programmed Antibacterial and Anti‐Inflammatory Effects via Steering NF‐κB Pathway for Infectious Cutaneous Regeneration | |
Sathish et al. | Biomedical applications of carrageenan hydrogel impregnated with zinc oxide nanoparticles | |
Sun et al. | A Self‐Powered Wound Dressing Based on “Lock‐ON/OFF” Drug Release Combined Electric Stimulus Therapy for Accelerated Infected Wound Healing | |
Yasuda et al. | [43] In vitro and in Vivo models of bacterial biofilms | |
CN111529682A (en) | Chemotaxis antibacterial nano material and preparation method and application thereof | |
Reid et al. | Surface properties of catheters, stents and bacteria associated with urinary tract infections | |
CN105381461B (en) | A kind of anti-biotic material and preparation method thereof with pH responses and light sensitivity | |
CN111494603A (en) | Antibacterial peptide nano ointment and preparation method and application thereof | |
Zhao et al. | Nature-inspired mechano-bactericidal nanostructured surfaces with photothermally enhanced antibacterial performances | |
Jawad et al. | Disinfection of drinking water from Escherichia coli and Pseudomonas aeruginosa by using silver nanoparticles | |
CN107602901A (en) | Antibiont coating material of high density grafting acidic group catalysis bacteria lysis and its preparation method and application | |
CN103463671B (en) | Antibacterial and antiviral sanitary pad | |
CN108721248A (en) | A kind of preparation method, product and the application of pH response type nanos silver assembly |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090520 Termination date: 20150725 |
|
EXPY | Termination of patent right or utility model |